Elanco Animal Health Cash Flow Statement
NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Elanco Animal Health free cash flow
In fiscal 2025, Elanco Animal Health generated $560.0 million of operating cash flow and spent $276.0 million on capital expenditures. That left free cash flow of $284.0 million, a free-cash-flow margin of 6.0% of revenue. Free cash flow was down 27.9% from the prior year's $394.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Elanco Animal Health cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -232.00M | 338.00M | -1.23B | -78.00M | -483.00M | -574.00M | 68.00M | 86.50M | -310.70M | -47.90M |
| Net Income growth (YoY) | -168.64% | — | — | — | — | -944.12% | -21.39% | — | — | — |
| Depreciation & Amortization | 680.00M | 662.00M | 694.00M | 682.00M | 716.00M | 517.00M | 314.00M | 296.00M | 318.40M | 254.40M |
| Stock-Based Compensation | 68.00M | 55.00M | 46.00M | 59.00M | 66.00M | 47.00M | 49.00M | 26.00M | 25.00M | 20.40M |
| Change in Working Capital | -48.00M | 67.00M | -206.00M | -364.00M | 19.00M | -193.00M | -199.00M | -145.30M | 61.90M | -206.50M |
| Operating Cash Flow | 560.00M | 541.00M | 271.00M | 452.00M | 483.00M | -41.00M | 224.00M | 487.30M | 173.80M | 155.90M |
| Capital Expenditures | -276.00M | -147.00M | -140.00M | -171.00M | -159.00M | -135.00M | -140.00M | -134.50M | -98.60M | -110.30M |
| Investing Cash Flow | -279.00M | 1.16B | -169.00M | -179.00M | -530.00M | -4.78B | -235.00M | -127.00M | -964.60M | -182.10M |
| Debt Issued | 2.11B | 350.00M | 0 | 425.00M | 500.00M | 4.80B | 0 | 2.50B | 0 | 0 |
| Debt Repaid | -2.67B | -1.60B | -402.00M | -677.00M | -573.00M | -952.00M | -121.00M | -7.50M | 0 | 0 |
| Financing Cash Flow | -275.00M | -1.49B | -83.00M | -549.00M | 210.00M | 4.95B | -305.00M | -35.20M | 847.50M | -149.60M |
| Net Change in Cash | 77.00M | 116.00M | 7.00M | -293.00M | 132.00M | 161.00M | -333.00M | 354.10M | 64.60M | -201.80M |
| Free Cash Flow | 284.00M | 394.00M | 131.00M | 281.00M | 324.00M | -176.00M | 84.00M | 352.80M | 75.20M | 45.60M |
This table shows 10 annual periods of Elanco Animal Health's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ELAN's reporting calendar. What is a cash flow statement?